tert-Butyl 4-(hydroxymethyl)benzyl(methyl)carbamate

Catalog No. :
ACMPFK174
CAS No. :
774238-90-3
Molecular Formula :
C14H21NO3
Molecular Weight :
251.33

IUPAC Name:tert-butyl (4-(hydroxymethyl)benzyl)(methyl)carbamate

tert-Butyl 4-(hydroxymethyl)benzyl(methyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$53.00Login to see priceIn stockIn stock
1g95%$171.00Login to see priceIn stockIn stock
5g95%$598.00Login to see priceIn stockIn stock
25g95%$2368.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-(hydroxymethyl)benzyl(methyl)carbamate
IUPAC Nametert-butyl (4-(hydroxymethyl)benzyl)(methyl)carbamate
MDL No.0
Molecular FormulaC14H21NO3
Molecular Weight251.33
SMILESO=C(OC(C)(C)C)N(CC1=CC=C(CO)C=C1)C
InChI KeyFZMVAYDGKFONJN-UHFFFAOYSA-N
Synonymtert-Butyl 4-(hydroxymethyl)benzyl(methyl)carbamate;Propanedioicacid,2-(2-propyn-5-yl)-,diethylester;Carbamic acid, N-[[4-(hydroxymethyl)phenyl]methyl]-N-methyl-, 1,1-dimethylethyl ester;tert-Butyl N-[4-(hydroxymethyl)benzyl]-N-methyl-carbamate;tert-butyl N-[[4-(hydroxymethyl)phenyl]methyl]-N-methylcarbamate
CAS No.774238-90-3
PubChem CID58392974

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACMPFK174 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMPFK174 route product structure diagram
    ACMPFK174774238-90-3 In Stock
Inquiry

2. ACMPFK174 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMPFK174 route product structure diagram
    ACMPFK174774238-90-3 In Stock
Inquiry

Comments (0)